NEW YORK, United States, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled Blood and “Blood Components Market By Product (Whole Blood, and Blood Components), By Application (Anemia, Trauma & Surgery, Cancer Treatment, and Bleeding Disorders), By Blood Components (Red Blood Cells, Platelets, Plasma, and White Blood Cells), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026” in its research database.
“According to the latest research study, the demand of global Blood and Blood Components Market size & share was valued at approximately USD 36,000 Million in 2020. The market is expected to grow at a Compound annual growth rate (CAGR) of 5.4% and is anticipated to reach around USD 47,000 Million by 2026.”
Report Overview:
Blood alludes to the liquid which flows in the vascular arrangement of the majority of creatures, as well as people. The red blood cells, white blood cells, platelets, and plasma are its four most important components. The blood and blood components are used in numerous medical treatments like bleeding disorders, cancer treatment, trauma and surgery, and anemia. Additionally, they are also broadly utilized in the surgery of severely traumatized patients and resuscitation applications.
Get a Free Sample PDF of this Research Report for more Insights with Table of Content, Research Methodology, and Graphs - https://www.fnfresearch.com/sample/blood-and-blood-components-market
Market Growth Dynamics
Industry Drivers:
- Increasing Occurrence of Trauma and Road Accidents
The growing occurrence of trauma and road accidents is a key factor driving the global blood and blood components market.
- Increase in the Number of Chronic Diseases
The increase in the number of chronic illnesses such as cancer, liver disease among others, and its high patient pool is likely to stimulate the blood and blood components market growth.
- Rising Incidence of Bleeding Disorders and Surgeries
In addition, the rising incidence of bleeding disorders and the growing number of surgeries worldwide are other growth factors that are expected to fuel the market expansion. Furthermore, the significant increase in the geriatric population that is exposed to various chronic disorders such as liver cirrhosis will generate a great demand for blood derivatives during the forecast period.
The rising awareness about the importance of blood donations between people along with the rising need for blood and blood derivatives in traumatic patients is also responsible for the influence of the demand for whole blood, which in turn, will boost the market growth.
Industry Restraints:
- Developing any Transfusion-transmitted Infection (TTI)
On the other hand, the increase in the possibility of developing any transfusion-transmitted infection (TTI) might hamper the growth of the market.
Key Offerings:
- Market Size & Forecast by Sales & Revenue | 2021−2026
- Market Dynamics – Top Trends, Growth Drivers, Restraints, and Investment Opportunities
- Market Segmentation – A detailed analysis by Product, Application, Blood Components, End-User, and Region
- Competitive Landscape – Leading Key Players and Other Prominent Vendors
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/blood-and-blood-components-market
Report Scope
| Report Attribute | Details |
| Market Size in 2020 | USD 36,000 Million |
| Projected Market Size in 2026 | USD 47,000 Million |
| CAGR Growth Rate | 5.4% CAGR |
| Base Year | 2020 |
| Forecast Years | 2021-2026 |
| Key Market Players | Medtronic Plc., American Red Cross, Abbott Laboratories, Australian Red Cross Blood Service, Blood Centers of America, German Red Cross, Becton Dickinson and Company, Nipro Medical Corporation, AVIS National, American Association of Blood Banks, National Blood Authority Australia, Baxter International Inc., Vitalant, CSL Behring, Novartis, Immucor, Novo Nordisk, Roche Diagnostics, Ortho Clinical Diagnostics, Grifols International SA, Fresenius Kabi, Medimmune (AstraZeneca), Thermo Fisher Scientific Inc., Sarstedt AG & Co., Terumo Corporation, Haemonetics Corporation, and Macopharma, and others |
| Key Segment | By Product, Application, Blood Components, End-User, and Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
| Purchase Options | Request customized purchase options to meet your research needs. Explore purchase options |
Segmentation Analysis
The global blood and blood components market is classified into product, application, blood components, and end-user. On the basis of the product, the global blood and blood components market is segmented into whole blood, and blood components. Based on the application, the global blood and blood components market is divided into anemia, trauma & surgery, cancer treatment, and bleeding disorders.
The global blood and blood components market based on the blood components is classified into red blood cells, platelets, plasma, and white blood cells. In terms of the end-user industry, the global blood and blood components market is categorized into hospitals, ambulatory surgical centers, and others.
Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/blood-and-blood-components-market
Regional Analysis
The global blood and blood components market can be classified into five major regional segments North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
- Asia-Pacific Will Dominate the Market during the Forecast Period
The region of Asia-Pacific will probably witness the fastest-growing market in the global blood and blood components market during the forecast period, owing to the growth factors like the advanced healthcare infrastructure and the existence of a high number of donors in this region. Other factors that are likely to fuel the Asia-Pacific market include the encouraging government initiatives as well as numerous untapped prospects in the rising markets of India and China.
Competitive Analysis
Sarstedt AG & Co., Australian Red Cross Blood Service, Haemonetics Corporation, Abbott Laboratories, Terumo Corporation, Blood Centers of America, Medtronic Plc., Becton Dickinson and Company, Macopharma, German Red Cross, Fresenius Kabi, Nipro Medical Corporation, Medimmune (AstraZeneca), American Association of Blood Banks, Grifols International SA, AVIS National, Roche Diagnostics, National Blood Authority Australia, Ortho Clinical Diagnostics, Vitalant, Novo Nordisk, Baxter International Inc., Novartis, CSL Behring, Immucor, Thermo Fisher Scientific Inc., and American Red Cross are some top companies operating in the global blood and blood components market.
Moreover, key players are adopting partnerships and collaborations to expand their customer base and create awareness in the global market.
Browse the full “Blood and Blood Components Market By Product (Whole Blood, and Blood Components), By Application (Anemia, Trauma & Surgery, Cancer Treatment, and Bleeding Disorders), By Blood Components (Red Blood Cells, Platelets, Plasma, and White Blood Cells), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026” report at https://www.fnfresearch.com/blood-and-blood-components-market
This report segments the global blood and blood components market as follows:
Global Blood and Blood Components Market: By Product
- Whole Blood
- Blood Components
Global Blood and Blood Components Market: By Application
- Anemia
- Trauma & Surgery
- Cancer Treatment
- Bleeding Disorders
Global Blood and Blood Components Market: By Blood Components
- Red Blood Cells
- Platelets
- Plasma
- White Blood Cells
Global Blood and Blood Components Market: By End-User
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Blood and Blood Components Market: Regional Segmentation Analysis
- North America
- The U.S.
- Canada
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of the Middle East & Africa
Key Insights from Primary Research
- As per the analysis, the global blood and blood components market is expected to grow at a CAGR of 5.4% Y-O-Y Growth Rate by 2026.
- The blood and blood components market is anticipated to reach around USD 47,000 Million during the forecast timeframe (2021-2026).
- Asia-Pacific will witness the fastest-growing region in the market during the forecast period.
Spectacular Deals
- Comprehensive coverage
- Maximum tables and figures
- Subscription-based option offered
- Best price guarantee
Request Your Free Sample Report of the Global Blood and Blood Components Market @ https://www.fnfresearch.com/sample/blood-and-blood-components-market
Browse Other Related Research Reports from Facts & Factors
- Blood Glucose Monitoring System Market: https://www.fnfresearch.com/blood-glucose-monitoring-system-market-report
- Tissue Culture Reagents Market: https://www.fnfresearch.com/tissue-culture-reagents-market-by-product-40-70m-1253
- Blood Filters Market: https://www.fnfresearch.com/blood-filters-market-by-product-40-70m-100m-1137
- Blood Collection Market: https://www.fnfresearch.com/blood-collection-market-by-product-serum-tube-plasma-1136
- DNA Forensics Market: https://www.fnfresearch.com/dna-forensics-market-report
Browse All Other Healthcare Industry Research Reports from Facts & Factors – https://www.fnfresearch.com/category/healthcare
About Facts & Factors:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us on Twitter: https://twitter.com/fnfresearch
Follow Us on Facebook: https://www.facebook.com/factsandfactors/
Contact Us:
Sanu Thomas
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 96043 17127
Email: sales@fnfresearch.com
Web: https://www.fnfresearch.com
Blog: https://ajayblogger.com/
